Abstract
While cerebellar ataxia (CA) is a neurodegenerative disease known for motor impairment, changes in mood have also been reported. A full account of neuropsychiatric symptomology in CA may guide improvements in treatment regimes, measure the presence and severity of sub-clinical neuropsychiatric disturbance symptomology in CA, and compare patient versus informant symptom recognition. Neuropsychiatric phenomena were gathered from CA patients with genetic and unknown etiologies and their informants (e.g., spouse or parent). Information was obtained from in-person interviews and the Center for Epidemiologic Studies Depression Scale. Responses were converted to the Neuropsychiatric Inventory-Questionnaire (NPI-Q) scores by consensus ratings. Patient NPI-Q scores were evaluated for symptom prevalence and severity relative to those obtained from healthy controls. Patient-informant NPI-Q score disagreements were evaluated. In this cohort, 95% of patients presented with at least one neuropsychiatric symptom and 51% of patients with three or more symptoms. The most common symptoms were anxiety, depression, nighttime behaviors (e.g., interrupted sleep), irritability, disinhibition, abnormal appetite, and agitation. The prevalence of these neuropsychiatric symptoms was uniform across patients with genetic versus unknown etiologies. Patient and informant symptom report disagreements reflected that patients noted sleep impairment and depression, while informants noted irritability and agitation. Neuropsychiatric disturbance is highly prevalent in patients with CA and contributes to the phenomenology of CA, regardless of etiology. Clinicians should monitor psychiatric health in their CA patients, considering that supplemental information from informants can help gauge the impact on family members and caregivers.
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs12311-020-01195-7/MediaObjects/12311_2020_1195_Fig1_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs12311-020-01195-7/MediaObjects/12311_2020_1195_Fig2_HTML.png)
Similar content being viewed by others
References
Ashizawa T, **a G. Ataxia. Continuum (Minneap Minn). 2016;22(4 Movement Disorders):1208–26.
Globas C, du Montcel ST, Baliko L, Boesch S, Depondt C, DiDonato S, et al. Early symptoms in Spinocerebellar Ataxia type 1, 2, 3, and 6. Mov Disord. 2008;23(15):2232–8.
Perlman S. Evaluation and management of ataxia disorders: an overview for physicians. 2016.
Baumann O, Borra RJ, Bower JM, Cullen KE, Habas C, Ivry RB, et al. Consensus paper: the role of the cerebellum in perceptual processes. Cerebellum. 2015;14(2):197–220.
Ferrari C, Oldrati V, Gallucci M, Vecchi T, Cattaneo Z. The role of the cerebellum in explicit and incidental processing of facial emotional expressions: a study with transcranial magnetic stimulation. Neuroimage. 2018;169:256–64.
Gottwald B, Mihajlovic Z, Wilde B, Mehdorn HM. Does the cerebellum contribute to specific aspects of attention? Neuropsychologia. 2003;41(11):1452–60.
Marvel CL, Desmond JE. The contributions of cerebro-cerebellar circuitry to executive verbal working memory. Cortex. 2010;46(7):880–95.
Marvel CL, Morgan OP, Kronemer SI. How the motor system integrates with working memory. Neurosci Biobehav Rev. 2019;102:184–94.
Stoodley CJ, Schmahmann JD. Functional topography in the human cerebellum: a meta-analysis of neuroimaging studies. Neuroimage. 2009;44(2):489–501.
Leroi I, O’Hearn E, Marsh L, Lyketsos CG, Rosenblatt A, Ross CA, et al. Psychopathology in patients with degenerative cerebellar diseases: a comparison to Huntington's disease. Am J Psychiatry. 2002;159(8):1306–14.
Liszewski CM, O'Hearn E, Leroi I, Gourley L, Ross CA, Margolis RL. Cognitive impairment and psychiatric symptoms in 133 patients with diseases associated with cerebellar degeneration. J Neuropsychiatr Clin Neurosci. 2004;16(1):109–12.
Klinke I, Minnerop M, Schmitz-Hübsch T, Hendriks M, Klockgether T, Wüllner U, et al. Neuropsychological features of patients with spinocerebellar ataxia (SCA) types 1, 2, 3, and 6. Cerebellum. 2010;9(3):433–42.
Lo RY, Figueroa KP, Pulst SM, Perlman S, Wilmot G, Gomez C, et al. Depression and clinical progression in spinocerebellar ataxias. Parkinsonism Relat Disord. 2016;22:87–92.
Clausi S, Lupo M, Olivito G, Siciliano L, Contento MP, Aloise F, et al. Depression disorder in patients with cerebellar damage: awareness of the mood state. J Affect Disord. 2019;245:386–93.
Fancellu R, Paridi D, Tomasello C, Panzeri M, Castaldo A, Genitrini S, et al. Longitudinal study of cognitive and psychiatric functions in spinocerebellar ataxia types 1 and 2. J Neurol. 2013;260(12):3134–43.
Muller AJ, Mills JMZ, O'Callaghan C, Naismith SL, Clouston PD, Lewis SJG, et al. Informant- and self-appraisals on the psychosis and hallucinations questionnaire (PsycH-Q) enhances detection of visual hallucinations in Parkinson's disease. Mov Disord Clin Pract. 2018;5(6):607–13.
McKinlay A, Grace RC, Dalrymple-Alford JC, Anderson TJ, Fink J, Roger D. Neuropsychiatric problems in Parkinson's disease: comparisons between self and caregiver report. Aging Ment Health. 2008;12(5):647–53.
Carone DA, et al. Interpreting patient/informant discrepancies of reported cognitive symptoms in MS. J Int Neuropsychol Soc. 2005;11(5):574–83.
Deck BL, et al. Cognitive functional abilities in Parkinson’s disease: agreement between patients and informants. Mov Disord Clin Pract. 2019;11(6):440–5.
Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas. 1977;1:385–401.
Kaufer DI, Cummings JL, Ketchel P, Smith V, MacMillan A, Shelley T, et al. Validation of the NPI-Q, a brief clinical form of the neuropsychiatric inventory. J Neuropsychiatr Clin Neurosci. 2000;12(2):233–9.
Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gornbein J. The neuropsychiatric inventory: comprehensive assessment of psychopathology in dementia. Neurology. 1994;44(12):2308–14.
Klockgether T, Mariotti C, Paulson HL. Spinocerebellar ataxia. Nat Rev Dis Primers. 2019;5(1):24.
Zurlo MC, Cattaneo Della Volta MF, Vallone F. The association between stressful life events and perceived quality of life among women attending infertility treatments: the moderating role of co** strategies and perceived couple’s dyadic adjustment. BMC Public Health. 2019;19(1):1548.
Wen FH, Chou WC, Chen JS, Chang WC, Hsieh CH, Shen WC, et al. Associations of preloss and postloss factors with severe depressive symptoms and quality of life over the first 2 years of bereavement for family caregivers of terminally ill cancer patients. Psychooncology. 2019;28(11):2157–65.
Wells R, Dywan J, Dumas J. Life satisfaction and distress in family caregivers as related to specific behavioural changes after traumatic brain injury. Brain Inj. 2005;19(13):1105–15.
Batelaan N, Smit F, Graaf R, Balkom A, Vollebergh W, Beekman A. Economic costs of full-blown and subthreshold panic disorder. J Affect Disord. 2007;104(1–3):127–36.
Levisohn L, Cronin-Golomb A, Schmahmann JD. Neuropsychological consequences of cerebellar tumour resection in children: cerebellar cognitive affective syndrome in a paediatric population. Brain. 2000;123(Pt 5):1041–50.
Heath RG. Modulation of emotion with a brain pacemaker - treatment for intractable psychiatric-illness. J Nerv Ment Dis. 1977;165(5):300–17.
Heath RG, Cox AW, Lustick LS. Brain activity during emotional states. Am J Psychiatr. 1974;131(8):858–62.
Turner BM, Paradiso S, Marvel CL, Pierson R, Boles Ponto LL, Hichwa RD, et al. The cerebellum and emotional experience. Neuropsychologia. 2007;45(6):1331–41.
Baumann O, Mattingley JB. Functional topography of primary emotion processing in the human cerebellum. Neuroimage. 2012;61(4):805–11.
Heath RG. Correlation of brain function with emotional behavior. Biol Psychiatry. 1976;11(4):463–80.
Turk KW, Flanagan ME, Josephson S, Keene CD, Jayadev S, Bird TD. Psychosis in Spinocerebellar ataxias: a case series and study of tyrosine hydroxylase in Substantia Nigra. Cerebellum. 2018;17(2):143–51.
Hoche F, Guell X, Vangel MG, Sherman JC, Schmahmann JD. The cerebellar cognitive affective/Schmahmann syndrome scale. Brain. 2018;141(1):248–70.
Schmahmann JD, Weilburg JB, Sherman JC. The neuropsychiatry of the cerebellum - insights from the clinic. Cerebellum. 2007;6(3):254–67.
Seidel K, et al. Brain pathology of spinocerebellar ataxias. Acta Neuropathol. 2012;124(1):1–21.
Romer AL, Knodt AR, Houts R, Brigidi BD, Moffitt TE, Caspi A, et al. Structural alterations within cerebellar circuitry are associated with general liability for common mental disorders. Mol Psychiatry. 2018;23(4):1084–90.
Adamaszek M, D'Agata F, Ferrucci R, Habas C, Keulen S, Kirkby KC, et al. Consensus paper: cerebellum and emotion. Cerebellum. 2017;16(2):552–76.
Bostan AC, Strick PL. The basal ganglia and the cerebellum: nodes in an integrated network. Nat Rev Neurosci. 2018;19(6):338–50.
Blatt G, Oblak A, Schmahmann J. Cerebellar Connections with Limbic Circuits: Anatomy and Functional Implications. Handbook of the Cerebellum and Cerebellar Disorders. 2013:479–96.
Moreno-Rius J. The cerebellum in fear and anxiety-related disorders. Prog Neuro-Psychopharmacol Biol Psychiatry. 2018;85:23–32.
Wolf U, Rapoport MJ, Schweizer TA. Evaluating the affective component of the cerebellar cognitive affective syndrome. J Neuropsychiatr Clin Neurosci. 2009;21(3):245–53.
Zesiewicz TA, Greenstein PE, Sullivan KL, Wecker L, Miller A, Jahan I, et al. A randomized trial of varenicline (Chantix) for the treatment of spinocerebellar ataxia type 3. Neurology. 2012;78(8):545–50.
Schmahmann JD, Sherman JC. The cerebellar cognitive affective syndrome. Brain. 1998;121:561–79.
Pla P, et al. Mood disorders in Huntington's disease: from behavior to cellular and molecular mechanisms. Front Behav Neurosci. 2014;8:135.
Acknowledgments
We would like to thank Shravi Lam for her help in gathering medication data. We would also like to thank the faculty and staff of the Johns Hopkins Ataxia Center and the National Ataxia Foundation for their support in providing testing resources at the 2017 Annual Ataxia Conference. Thank you to the patients and families who interviewed with us for this study.
Funding
This study was funded by NINDS, The Gordon and Marylin Macklin Foundation, The Jane Tanger Black Fund for Young-Onset Dementias, The Nancy H. Hall Fund for Geriatric Psychiatry, and the Margaret Q. Landenberger Research Foundation.
Author information
Authors and Affiliations
Contributions
The study was conceptualized by Sharif Kronemer, Liana Rosenthal, Chiadi Onyike, and Cherie Marvel. Material preparation and data collection and processing were completed by Sharif Kronemer, Mitchell Slapik, Jessica Pietrowski, Michael Margron, Owen Morgan, Catherine Bakker, Liana Rosenthal, Chiadi Onyike, and Cherie Marvel. Analyses were completed by Sharif Kronemer and Cherie Marvel. Sharif Kronemer, Chiadi Onyike, and Cherie Marvel drafted the manuscript. All authors reviewed and approved the manuscript. Funding was provided by Sharif Kronemer (National Institute of Neurological Disorders and Stroke, T32 NS007224), Liana Rosenthal (The Gordon and Marylin Macklin Foundation), Chiadi Onyike (The Jane Tanger Black Fund for Young-Onset Dementias and the Nancy H. Hall Fund for Geriatric Psychiatry), and Cherie Marvel (The Margaret Q. Landenberger Research Foundation).
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that they have no conflict of interest.
Ethics Approval
All study procedures were approved by the Institutional Review Board at Johns Hopkins University and performed in accordance with the Declaration of Helsinki.
Consent to Participate
Informed consent was obtained from all participants prior to participating in this study.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Kronemer, S.I., Slapik, M.B., Pietrowski, J.R. et al. Neuropsychiatric Symptoms as a Reliable Phenomenology of Cerebellar Ataxia. Cerebellum 20, 141–150 (2021). https://doi.org/10.1007/s12311-020-01195-7
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12311-020-01195-7